Atrial cardiomyopathy not only occurs with aging but also results from many pathophysiological conditions, including systemic inflammatory conditions and low-grade subclinical inflammatory conditions (hypertension, heart failure, coronary artery disease, and so on) (41–43); these factors interact with each other, leading to activation of the renin–angiotensin–aldosterone system (RAAS) and production of angiotensin II (Ang II) with the potential to induce cardiomyocyte hypertrophy, endothelial abnormalities, and myocardial fibrosis. This evidence concerns the gene AGT and heart failure.